HOME >> BIOLOGY >> NEWS
Ligand Scientists Discover Tissue-Selective Female Hormone Mimics

The Journal of Medicinal Chemistry Highlights Discovery of First Progesterone Mimic To Act Selectively On Uterine Cells And Reproductive Tract With Reduced Impact On Breast Cells

SAN DIEGO, Calif., June 23, 1998--Scientists from Ligand (LYE-gand) Pharmaceuticals Incorporated (Nasdaq: LGND) have discovered "designer" progestins that show a protective activity in the uterus without concomitant stimulation of breast-cell growth. Research surrounding this discovery was released today by the Journal of Medicinal Chemistry, a leading peer-reviewed journal for discoveries in the medicinal chemistry field. Data featured in the journal describe two novel non-steroidal progestin compounds, (S)-LG120746 and (S)-LG120747 that were tested in animal models and demonstrated the ability to selectively stimulate tissues within the body.

Currently available steroidal progestins, which are most often used in hormone replacement therapy and birth control, do not exhibit this ability to discern between tissues or cell types. All progestins used in clinical practice today are steroids, and while they provide a positive benefit, they also carry the potential of enhancing cancer risk in women since they can stimulate cellular proliferation in several types of tissues--most notably breast tissue.

"With this publication, Ligand has revealed the discovery of a completely novel progesterone receptor pharmacophore that may have distinct clinical advantages over currently available steroidal progestin therapies," said Dr. Andrés Negro-Vilar, Ligand Senior Vice President and Chief Scientific Officer. "These compounds should provide a clear benefit when used in hormone replacement therapy and other important female health applications."

Ligand's research team recognized (S)-LG120746's and (S)-LG120747's progestin effect through the application of three in vivo tests or assays. The scientists applied these assays to the
'"/>

Contact: Mary Kenny
mkenny@ligand.com
619-550-7536
Ligand Pharmaceuticals Incorporated
23-Jun-1998


Page: 1 2 3

Related biology news :

1. Researchers Find Fas Ligand Is Important In Blinding Disease
2. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
3. Scientists sequence genome of kind of organism central to biospheres carbon cycle
4. Scientists find nanowires capable of detecting individual viruses
5. Scientists discover potential new way to control drug-resistant bacteria
6. Scientists explore genome of methane-breathing microbe
7. Scientists decipher genetic code of biothreat pathogen
8. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
9. Scientists discover proteins involved in spread of HIV-1 infection
10. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
11. Scientists reinvent DNA as template to produce organic molecules

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... ... 2020 , ... Commercial launch readiness is a critical stage in a product ... or vaccine, the global economic downturn will only increase price pressures overall for the ... capturing full value from every product launch is critical. However, history shows that only ...
(Date:7/2/2020)... CITY, Calif. (PRWEB) , ... July 01, 2020 ... ... biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the ... conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... solutions for biopharmaceutical R&D, today announced that it has entered into a ... multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy to ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 12, 2020 , ... ... International), a global leader in FDA compliance consulting has been named on its ... companies. The list represents a unique look at the most successful companies within ...
(Date:7/31/2020)... ... 29, 2020 , ... G-CON Manufacturing, the leader in off-site ... FOR LIFE.” The adoption of this taglines comes at a time of tremendous ... to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. G-CON’s ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... 200 of the top radiation centers in 16 countries, has reached its 20th ... SDX® is now in routine use at top universities including University of Pennsylvania, ...
(Date:7/18/2020)... Ohio (PRWEB) , ... July 16, 2020 , ... ... data solutions to aid in the early detection and prevention of high-burden diseases, ... to enable US-based hospitals and healthcare organizations to utilize existing data in order ...
Breaking Biology Technology:
Cached News: